Cancer of the Breast
Epidemiology, Diagnostics and Treatment
- 1st Edition - November 23, 2024
- Imprint: Academic Press
- Editors: Dharambir Kashyap, Riya Sharma, Vivek Kumar Garg, Huda Salman
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 4 8 3 8 - 2
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 4 8 3 9 - 9
Cancer of the Breast: Epidemiology, Diagnostics and Treatment comprehensively examines all aspects of breast cancer, including classification, risk factors involved, and preven… Read more
Purchase options
Cancer of the Breast: Epidemiology, Diagnostics and Treatment comprehensively examines all aspects of breast cancer, including classification, risk factors involved, and prevention. While offering in-depth coverage of breast cancer biology and current therapies, the book also provides insights into the fields of cancer genetics and prevention, as well as surveillance strategies against breast cancer. Readers will find multidisciplinary approaches that promote the interaction between basic research and clinical research in the fields of oncology, genetics, and molecular biology.
This book is a valuable resource for health professionals, researchers, health practitioners, graduate and medical students, and anyone who wishes to broaden their knowledge in the allied field.
This book is a valuable resource for health professionals, researchers, health practitioners, graduate and medical students, and anyone who wishes to broaden their knowledge in the allied field.
- Offers a comprehensive summary of breast cancer initiation and progression
- Explores risk factors and advances in the reduction of breast cancer risks
- Includes coverage of genetic counselling and methods of self-screening for breast cancer
- Covers future perspective in breast cancer diagnostic tools and treatment strategies
Researchers working across the biosciences in fields of oncology, cancer biology, translational cancer research, and cancer genetics
1. Epidemiology of breast cancer
2. Risk factors for breast cancer: knowledge and prevention
3. Histological and molecular classification of breast cancer: Basic understanding
4. Breast cancer stromal and its components: implication in diagnostic and therapeutic
5. Genetic behind breast cancer: Germline and somatic factors
6. Heterogeneity of breast cancer: a major cause of therapy failure
7. Recent advancement in molecular tools for breast cancer diagnosis and trends in future perspective
8. Recent development in treatment strategies for breast cancer: With special reference to immunotherapy
9. Liquid biopsy: A non-invasive tool in breast cancer diagnosis
10. Protein biomarkers in breast cancer: Implication in diagnosis and prognosis
11. Understanding of therapeutic resistance: With special resistance to breast cancer
12. Breast Cancer Stem Cell: Role in Carcinogenesis
13. Plant derived biomolecules: role in breast cancer initiation and progression
2. Risk factors for breast cancer: knowledge and prevention
3. Histological and molecular classification of breast cancer: Basic understanding
4. Breast cancer stromal and its components: implication in diagnostic and therapeutic
5. Genetic behind breast cancer: Germline and somatic factors
6. Heterogeneity of breast cancer: a major cause of therapy failure
7. Recent advancement in molecular tools for breast cancer diagnosis and trends in future perspective
8. Recent development in treatment strategies for breast cancer: With special reference to immunotherapy
9. Liquid biopsy: A non-invasive tool in breast cancer diagnosis
10. Protein biomarkers in breast cancer: Implication in diagnosis and prognosis
11. Understanding of therapeutic resistance: With special resistance to breast cancer
12. Breast Cancer Stem Cell: Role in Carcinogenesis
13. Plant derived biomolecules: role in breast cancer initiation and progression
- Edition: 1
- Published: November 23, 2024
- Imprint: Academic Press
- Language: English
DK
Dharambir Kashyap
Dr. Kashyap is currently at the Brown Center for Immunotherapy, Indiana University, working on identifying novel biomarkers for designing and modifying immunotherapy approaches for breast cancer targeting TME components. He received his PhD in molecular biology on the main subject of tumor microenvironment in breast cancer from PGIMER, Chandigarh, India, and holds an MSc in Human Genomics. He published 70 articles and five book chapters. He is also a reviewer and editorial board member of many PubMed/Scopus-indexed journals. His h-index is 26, and FWCI is 2.91
Affiliations and expertise
Brown Center for Immunotherapy, Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.RS
Riya Sharma
Dr. Sharma is an early career scientist in biological science at the School of Medicine, Indiana University Indianapolis, USA, working on Multiple Myeloma genomics characterizations. She holds an MSc in Microbial Biotechnology and has good publications in peer-reviewed international journals.
Affiliations and expertise
Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USAVG
Vivek Kumar Garg
Dr. Garg is currently an Associate Professor at Chandigarh University in India. In 2018, he earned his PhD in Neurology and holds his M.Sc. in Medical Biochemistry. He has published 47 articles in prestigious journals and 12 book chapters. He is also a reviewer and editorial board member of 12 PubMed/Scopus-indexed journals.
Affiliations and expertise
Department of Medical Lab Technology, University Institute of Allied Health Sciences, Chandigarh University, Gharuan, Mohali, Punjab, IndiaHS
Huda Salman
Dr. Salman is Director of the Brown Center for Immunotherapy, Co-leader of the HHM CC Program, Don Brown Professor of Immunotherapy, and Professor of the Department of Medicine, Microbiology and Immunology, Indiana University, Indianapolis, IN 46202. She holds the MD and PhD in Medicine. She is on the editorial board of several journals with a high impact factor. She is mentioned as America’s most honored doctor (2020-2022). She has published several articles. Her expertise is in the engineering and manufacturing Chimeric Antigen Receptor T-cells (CAR-T cells) for treating hematological malignancies and solid tumors.
Affiliations and expertise
Brown Center for Immunotherapy, Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USARead Cancer of the Breast on ScienceDirect